Childhood and adolescent obesity and long-term cognitive consequences during aging

Journal of Comparative Neurology

Volumn 523, Issue 5, 2015, Pages 757-768

  Wang, Jun ^a,b   Freire, Daniel ^a   Knable, Lindsay ^a   Zhao, Wei ^a   Gong, Bing ^a   Mazzola, Paolo ^a,c   Ho, Lap ^a   Levine, Samara ^a   Pasinetti, Giulio M ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Aging; Cognitive function; Insulin resistance; Obesity; Synaptic plasticity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; HISTONE DEACETYLASE 5; HDAC5 PROTEIN, MOUSE; HISTONE DEACETYLASE;

ADOLESCENT OBESITY; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; C57BL 6 MOUSE; CHILDHOOD OBESITY; COGNITION; COGNITIVE DEFECT; CONDITIONING; CONTROLLED STUDY; DNA MODIFICATION; FEAR; FEMALE; GENE EXPRESSION; GLUCOSE TOLERANCE; HIPPOCAMPUS; HOMEOSTASIS; INSULIN RESISTANCE; LEARNING DISORDER; LIPID DIET; LOW FAT DIET; MEMORY CONSOLIDATION; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPATIAL MEMORY TEST; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; GENETIC EPIGENESIS; GROWTH, DEVELOPMENT AND AGING; MEMORY DISORDER; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RANDOMIZATION; SPATIAL MEMORY; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUE;

AGING; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; FEMALE; HISTONE DEACETYLASES; INSULIN RESISTANCE; LEARNING DISORDERS; MEMORY DISORDERS; MICE, INBRED C57BL; OBESITY; RANDOM ALLOCATION; SPATIAL MEMORY; SYNAPTIC TRANSMISSION; TISSUE CULTURE TECHNIQUES;

EID: 84921559150     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23708     Document Type: Article

References (47)

1. Anderson SE, Cohen P, Naumova EN, Jacques PF, Must A. 2007. Adolescent obesity and risk for subsequent major depressive disorder and anxiety disorder: prospective evidence. Psychosom Med 69:740-747.
2. Biessels GJ, Deary IJ, Ryan CM. 2008. Cognition and diabetes: a lifespan perspective. Lancet Neurol 7:184-190.
3. Buttitta M, Iliescu C, Rousseau A, Guerrien A. 2014. Quality of life in overweight and obese children and adolescents: a literature review. Qual Life Res 23:1117-1139.
4. Calcaterra V, Klersy C, Muratori T, Telli S, Caramagna C, Scaglia F, Cisternino M, Larizza D. 2008. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol 68:868-872.
5. Coleman P, Federoff H, Kurlan R. 2004. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63:1155-1162.
6. Daniels SR. 2009. Complications of obesity in children and adolescents. Int J Obes 33(suppl 1):S60-S65.
7. De Niet JE, Naiman DI. 2011. Psychosocial aspects of childhood obesity. Minerva Pediatr 63:491-505.
8. Dietz WH. 1998. Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 101:518-525.
9. Dietz WH, Bandini LG, Gortmaker S. 1990. Epidemiologic and metabolic risk factors for childhood obesity. Prepared for the Fourth Congress on Obesity Research, Vienna, Austria, December, 1988. Klin Padiatr 202:69-72.
10. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW. 2007. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 30:2655-2660.
11. Gerges NZ, Aleisa AM, Alkadhi KA. 2003. Impaired long-term potentiation in obese zucker rats: possible involvement of presynaptic mechanism. Neuroscience 120:535-539.
12. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. 2009. The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9:88.
13. Halliday JA, Palma CL, Mellor D, Green J, Renzaho AM. 2014. The relationship between family functioning and child and adolescent overweight and obesity: a systematic review. Int J Obes 38:480-493.
14. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. 2004. Prevalence of overweight and obesity among US children, adolescents, adults, 1999-2002. JAMA 291:2847-2850.
15. Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM. 2004. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 18:902-904.
16. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE. 2006. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103:5161-5166.
17. Janicke DM, Steele RG, Gayes LA, Lim CS, Clifford LM, Schneider EM, Carmody JK, Westen S. 2014. Systematic review and meta-analysis of comprehensive behavioral family lifestyle interventions addressing pediatric obesity. J Pediatr Psychol (in press).
18. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R. 2007. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 23:29-34.
19. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL. 2004. Synaptic Targeting by Alzheimer's-related amyloid β oligomers. J Neurosci 24:10191-10200.
20. Li C, Ford ES, Zhao G, Mokdad AH. 2009. Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006. Diabetes Care 32:342-347.
21. Ct method. Methods 25:402-408.
22. Mauvais-Jarvis F, Clegg DJ, Hevener AL. 2013. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34:309-338.
23. McNay EC. 2005. The impact of recurrent hypoglycemia on cognitive function in aging. Neurobiol Aging 26(Suppl 1):76-79.
24. Morley JE. 2004. The metabolic syndrome and aging. J Gerontol A Biol Sci Med Sci 59:139-142.
25. Morris R. 1984. Developments of a water-maze procedure for studying spatial-learning in the rat. J Neurosci Methods 11:47-60.
26. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. 2007. Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24:185-192.
27. Pancani T, Anderson KL, Brewer LD, Kadish I, DeMoll C, Landfield PW, Blalock EM, Porter NM, Thibault OL. 2013. Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats. Neurobiol Aging 34:1977-1987.
28. Razay G, Vreugdenhil A, Wilcock G. 2007. The metabolic syndrome and Alzheimer disease. Arch Neurol 64:93-96.
29. Scheff SW, Price DA. 2003. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 24:1029-1046.
30. Selkoe DJ. 2002. Alzheimer's disease is a synaptic failure. Science 298:789-791.
31. Selkoe DJ. 2008. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106-113.
32. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL. 2007. Natural oligomers of the alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875.
33. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ. 2008. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14:837-842.
34. Shi H, Seeley RJ, Clegg DJ. 2009. Sexual differences in the control of energy homeostasis. Front Neuroendocrinol 30:396-404.
35. Steele JW, Lachenmayer ML, Ju S, Stock A, Liken J, Kim SH, Delgado LM, Alfaro IE, Bernales S, Verdile G, Bharadwaj P, Gupta V, Barr R, Friss A, Dolios G, Wang R, Ringe D, Fraser P, Westaway D, St. George-Hyslop PH, Szabo P, Relkin NR, Buxbaum JD, Glabe CG, Protter AA, Martins RN, Ehrlich ME, Petsko GA, Yue Z, Gandy S. 2012. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model. Mol Psychiatry 18:889-897.
36. Stranahan AM, Norman ED, Lee K, Cutler RG, Telljohann RS, Egan JM, Mattson MP. 2008. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18:1085-1088.
37. Terry RD, Masliah E, Salmon DP, Butters N, Deteresa R, Hill R, Hansen LA, Katzman R. 1991. Physical basis of cognitive alterations in Alzheimers-disease-synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
38. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. 2006. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525.
39. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG. 2007. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 69:979-985.
40. Walsh DM, Selkoe DJ. 2007. A beta oligomers-a decade of discovery. J Neurochem 101:1172-1184.
41. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. 2002. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539.
42. Wang J, Ho L, Qin W, Rocher AB, Seror I, Humala N, Maniar K, Dolios G, Wang R, Hof PR, Pasinetti GM. 2005. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J 19:659-661.
43. Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, Humala N, Seror I, Bartholomew S, Rosendorff C, Pasinetti GM. 2007. Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 117:3393-3402.
44. Wang J, Gong B, Zhao W, Tang C, Varghese M, Nguyen T, Bi W, Bilski A, Begum S, Vempati P, Knable L, Ho L, Pasinetti GM. 2013. Epigenetic mechanisms linking diabetes and synaptic impairments. Diabetes 63:645-654.
45. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. 1997. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 337:869-873.
46. Williams CL, Gulli MT, Deckelbaum RJ. 2001. Prevention and treatment of childhood obesity. Curr Atheroscler Rep 3:486-497.
47. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N. 2007. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55:758-762.